The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Morganella


High impact information on Morganella


Chemical compound and disease context of Morganella


Biological context of Morganella


Anatomical context of Morganella


Gene context of Morganella


Analytical, diagnostic and therapeutic context of Morganella


  1. Aztreonam susceptibility testing. A retrospective analysis. Parry, M.F. Am. J. Med. (1990) [Pubmed]
  2. Cefotaxime combined with selective decontamination in long term intensive care unit patients. Virtual absence of emergence of resistance. van Saene, H.K., Stoutenbeek, C.P., Zandstra, D.F. Drugs (1988) [Pubmed]
  3. Pyridoxal 5'-phosphate dependent histidine decarboxylase: overproduction, purification, biosynthesis of soluble site-directed mutant proteins, and replacement of conserved residues. Vaaler, G.L., Snell, E.E. Biochemistry (1989) [Pubmed]
  4. Antibacterial activity of BMS-180680, a new catechol-containing monobactam. Fung-Tomc, J., Bush, K., Minassian, B., Kolek, B., Flamm, R., Gradelski, E., Bonner, D. Antimicrob. Agents Chemother. (1997) [Pubmed]
  5. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases. Mushtaq, S., Ge, Y., Livermore, D.M. Antimicrob. Agents Chemother. (2004) [Pubmed]
  6. Purification and properties of a pyridoxal 5'-phosphate-dependent histidine decarboxylase from Morganella morganii AM-15. Tanase, S., Guirard, B.M., Snell, E.E. J. Biol. Chem. (1985) [Pubmed]
  7. Biochemical and molecular characterization of three new variants of AmpC beta-lactamases from Morganella morganii. Power, P., Galleni, M., Ayala, J.A., Gutkind, G. Antimicrob. Agents Chemother. (2006) [Pubmed]
  8. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Ruzin, A., Keeney, D., Bradford, P.A. Antimicrob. Agents Chemother. (2005) [Pubmed]
  9. TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Perilli, M., Segatore, B., de Massis, M.R., Riccio, M.L., Bianchi, C., Zollo, A., Rossolini, G.M., Amicosante, G. Antimicrob. Agents Chemother. (2000) [Pubmed]
  10. Molecular characterization of a ceftazidime-resistant Morganella morganii isolate producing a TEM-10 beta-lactamase. Barroso, H., Freitas-Vieira, A., Duarte, A. Antimicrob. Agents Chemother. (1999) [Pubmed]
  11. Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam. Kuck, N.A., Jacobus, N.V., Petersen, P.J., Weiss, W.J., Testa, R.T. Antimicrob. Agents Chemother. (1989) [Pubmed]
  12. Molecular characterization of a TEM-21 beta-lactamase in a clinical isolate of Morganella morganii. Tessier, F., Arpin, C., Allery, A., Quentin, C. Antimicrob. Agents Chemother. (1998) [Pubmed]
  13. In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria: effect on urease activity and on cell surface hydrophobicity. Ramadan, M.A., Tawfik, A.F., el-Kersh, T.A., Shibl, A.M. J. Infect. Dis. (1995) [Pubmed]
  14. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Fass, R.J., Prior, R.B. Antimicrob. Agents Chemother. (1989) [Pubmed]
  15. Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Barnaud, G., Arlet, G., Verdet, C., Gaillot, O., Lagrange, P.H., Philippon, A. Antimicrob. Agents Chemother. (1998) [Pubmed]
  16. Tigemonam, an oral monobactam. Chin, N.X., Neu, H.C. Antimicrob. Agents Chemother. (1988) [Pubmed]
  17. Description of In116, the first blaCTX-M-2-containing complex class 1 integron found in Morganella morganii isolates from Buenos Aires, Argentina. Power, P., Galleni, M., Di Conza, J., Ayala, J.A., Gutkind, G. J. Antimicrob. Chemother. (2005) [Pubmed]
  18. Phosphorylation of nucleosides by the mutated acid phosphatase from Morganella morganii. Mihara, Y., Utagawa, T., Yamada, H., Asano, Y. Appl. Environ. Microbiol. (2000) [Pubmed]
  19. C-reactive protein and antibacterial activity in blood plasma of colostrum-fed calves and the effect of lactulose. Schroedl, W., Jaekel, L., Krueger, M. J. Dairy Sci. (2003) [Pubmed]
  20. Fatal early onset infection in an extremely low birth weight infant due to Morganella morganii. Ranu, S.S., Valencia, G.B., Piecuch, S. Journal of perinatology : official journal of the California Perinatal Association. (1999) [Pubmed]
  21. Bacterial acid phosphatase gene fusions useful as targets for cloning-dependent insertional inactivation. Thaller, M.C., Berlutti, F., Schippa, S., Selan, L., Rossolini, G.M. Biotechnol. Prog. (1998) [Pubmed]
  22. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam. Neu, H.C. Antimicrob. Agents Chemother. (1982) [Pubmed]
  23. The in-vitro activity of faropenem, a novel oral penem. Woodcock, J.M., Andrews, J.M., Brenwald, N.P., Ashby, J.P., Wise, R. J. Antimicrob. Chemother. (1997) [Pubmed]
  24. Structural investigation of the O-specific polysaccharides of Morganella morganii consisting of two higher sugars. Kilcoyne, M., Shashkov, A.S., Senchenkova, S.A., Knirel, Y.A., Vinogradov, E.V., Radziejewska-Lebrecht, J., Galimska-Stypa, R., Savage, A.V. Carbohydr. Res. (2002) [Pubmed]
  25. Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result. Jones, R.N., Zurenko, G.E. Diagn. Microbiol. Infect. Dis. (1993) [Pubmed]
  26. Properties and participation of "free" endotoxin in the toxic activity of Morganella morganii. Bartková, G., Majtán, V. Folia Microbiol. (Praha) (1988) [Pubmed]
WikiGenes - Universities